Literature DB >> 9152989

Evidence of linkage between the serotonin transporter and autistic disorder.

E H Cook1, R Courchesne, C Lord, N J Cox, S Yan, A Lincoln, R Haas, E Courchesne, B L Leventhal.   

Abstract

The serotonin transporter gene (HTT) is a primary candidate in autistic disorder based on efficacy of potent serotonin transporter inhibitors in reducing rituals and routines. We initiated a candidate gene study of HTT in trios consisting of probands with autistic disorder and both parents. Preliminary transmission/disequilibrium test (TDT) analysis with 86 families revealed no evidence for linkage or linkage disequilibrium between autistic disorder and a polymorphism in the second intron of HTT. However, preferential transmission of a short variant of the HTT promoter was found in the same 86 trios (TDT chi 2 = 4.69, 1 d.f., P = 0.030). In further analyses, we considered haplotypes of the HTT promoter variant and second intron locus as alleles in a multiallelic TDT. Results confirmed the significance of the effect of this region (TDT chi 2 = 11.85, 4 d.f., P = 0.018). This provides preliminary evidence of linkage and association between HTT and autistic disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152989     DOI: 10.1038/sj.mp.4000266

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  91 in total

Review 1.  The pathophysiology and treatment of autism.

Authors:  D J Posey; C J McDougle
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  Heterogeneity and the genetics of autism.

Authors:  P Szatmari
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 3.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

4.  Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Authors:  C J McDougle; L E Kresch; D J Posey
Journal:  J Autism Dev Disord       Date:  2000-10

Review 5.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

6.  Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Authors:  Yoko Sugie; Hideo Sugie; Tokiko Fukuda; Masataka Ito; Yumiko Sasada; Mutsumi Nakabayashi; Kazunobu Fukashiro; Takehiko Ohzeki
Journal:  J Autism Dev Disord       Date:  2005-06

7.  The overlap between alexithymia and Asperger's syndrome.

Authors:  Michael Fitzgerald; Mark A Bellgrove
Journal:  J Autism Dev Disord       Date:  2006-05

Review 8.  Autism: in search of susceptibility genes.

Authors:  Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

9.  Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial.

Authors:  S H Fatemi; G M Realmuto; L Khan; P Thuras
Journal:  J Autism Dev Disord       Date:  1998-08

10.  Enhanced activity of human serotonin transporter variants associated with autism.

Authors:  Harish C Prasad; Jennifer A Steiner; James S Sutcliffe; Randy D Blakely
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.